Status:
COMPLETED
Blood-borne Infection Screening in an Afghan Antenatal Population
Lead Sponsor:
Columbia University
Collaborating Sponsors:
Fogarty International Center of the National Institute of Health
Conditions:
Viral Hepatitis B
Contraception
Eligibility:
All Genders
14-65 years
Phase:
NA
Brief Summary
Baseline information indicates there are measurable levels of hepatitis B SAg and low utilization of postpartum contraception, correct breastfeeding practices, or adherence to infant vaccination sched...
Detailed Description
Outcomes are assessed through questionnaire responses and inspection of vaccination cards at six month intervals by trained study staff through one year total study time. Differences between groups wi...
Eligibility Criteria
Inclusion
- admitted for obstetric care
- Dari or Pashto speaking
- not previously participated in the study
- in medically stable condition
- accompanied by and have approval of a spouse
- able to provide informed consent
- Male participants must be the confirmed spouses of the female participants, have a working telephone, and able to provide informed consent.
Exclusion
- medically unstable or imminently delivering (complete cervical dilation)
- husband unavailable or does not approve participation
- unable to provide consent
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2010
Estimated Enrollment :
1291 Patients enrolled
Trial Details
Trial ID
NCT01199601
Start Date
June 1 2008
End Date
May 1 2010
Last Update
May 17 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maternity Hospitals
Kabul, Afghanistan